Search
Showing results for "8"
Research
Safety and immunogenicity of a booster dose of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: A randomized phase 1 studyImmune responses after the initial vaccination persisted for the 12 months studied, with little additional response after the booster dose at 6 months
Research
Cross-presentation of cutaneous melanoma antigen by migratory XCR1+CD103− and XCR1+CD103+ dendritic cellsThis report provides new insight into the functional specialization within the broad network of dendritic cells that are responsible for skin immunosurveillance
Research
Does walkable neighbourhood design influence the association between objective crime and walking?This study examined associations between objective crime and walking, controlling for the characteristics of walkable neighbourhoods.
Research
Are autistic traits in the general population stable across development?The current investigation measured AT in 360 males and 400 males from the general population close to two decades apart, using the Pervasive Developmental...
The Opportunity The People & Culture team are looking for a dynamic and innovative individual to fill a newly created position of OSH Coordinatoron a
Assessment of p.Phe508del-CFTR functional restoration in pediatric primary cystic fibrosis airway epithelial cells Abstract Background Mutations in
The social and emotional wellbeing of Aboriginal children and young people
News & Events
Thanks for coming to our Open DayThank you to everyone who visited The Kids Research Institute Australia's Open Day on October 8. We welcomed more than 700 guests to the Institute to discover our research.
Research
Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver diseaseNonalcoholic fatty liver disease (NAFLD) is a predominantly adult-diagnosed disorder. Knowledge regarding the epidemiology, phenotype, and metabolic risk...
Research
A randomized phase I study of the safety and immunogenicityIn this study of healthy adults aged 50-85 and 18-24 years, SA3Ag elicited a rapid and robust immune response and was well tolerated, with no notable safety...